B. Riley Securities Downgrades Macrogenics to Neutral, Lowers Price Target to $5
Portfolio Pulse from Benzinga Newsdesk
B. Riley Securities has downgraded Macrogenics (NASDAQ:MGNX) from Buy to Neutral and lowered the price target from $18 to $5.
July 31, 2024 | 9:58 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
B. Riley Securities downgraded Macrogenics from Buy to Neutral and significantly lowered the price target from $18 to $5.
The downgrade from Buy to Neutral and the drastic reduction in the price target from $18 to $5 by B. Riley Securities is likely to negatively impact investor sentiment and the stock price of Macrogenics in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100